From Casetext: Smarter Legal Research

Cephalon, Inc. v. Watson Pharm., Inc.

United States Court of Appeals, Federal Circuit
Oct 13, 2011
No. 2011-1325 (Fed. Cir. Oct. 13, 2011)

Opinion

2011-1325

10-13-2011

CEPHALON, INC. AND CIMA LABS, INC., Plaintiffs-Appellants, v. WATSON PHARMACEUTICALS, INC., WATSON LABORATORIES, INC., AND WATSON PHARMA, INC., Defendants-Appellees.


NOTE: This order is nonprecedential.


Appeal from the United States District Court for the

District of Delaware in case no. 08-CV-0330, Judge Sue L.

Robinson.


ON MOTION


ORDER

Cephalon, Inc. and CIMA Labs, Inc., move for a 30-day extension of time, until November 16, 2011, to file their opening brief due to settlement negotiations.

Upon consideration thereof,

IT IS ORDERED THAT:

The motion is granted. No further extensions should be anticipated.

FOR THE COURt

Jan Horbaly

Clerk

cc: William F. Lee, Esq.

James K. Stronski, Esq.


Summaries of

Cephalon, Inc. v. Watson Pharm., Inc.

United States Court of Appeals, Federal Circuit
Oct 13, 2011
No. 2011-1325 (Fed. Cir. Oct. 13, 2011)
Case details for

Cephalon, Inc. v. Watson Pharm., Inc.

Case Details

Full title:CEPHALON, INC. AND CIMA LABS, INC., Plaintiffs-Appellants, v. WATSON…

Court:United States Court of Appeals, Federal Circuit

Date published: Oct 13, 2011

Citations

No. 2011-1325 (Fed. Cir. Oct. 13, 2011)